1. Home
  2. VYGR vs XWIN Comparison

VYGR vs XWIN Comparison

Compare VYGR & XWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

XWIN

XMAX Inc.

N/A

Current Price

$6.23

Market Cap

259.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
XWIN
Founded
2013
2003
Country
United States
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
259.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
XWIN
Price
$3.76
$6.23
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
837.1K
607.5K
Earning Date
03-09-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
$54.19
N/A
Revenue Next Year
$20.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$5.20
52 Week High
$5.55
$6.39

Technical Indicators

Market Signals
Indicator
VYGR
XWIN
Relative Strength Index (RSI) 43.57 55.42
Support Level $3.60 $5.53
Resistance Level $4.43 $6.35
Average True Range (ATR) 0.33 0.11
MACD -0.03 -0.01
Stochastic Oscillator 4.37 57.69

Price Performance

Historical Comparison
VYGR
XWIN

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About XWIN XMAX Inc.

XMax Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: